Literature DB >> 18691339

Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma.

Koji Fukase1, Hideo Ohtsuka, Tohru Onogawa, Hiroshi Oshio, Takayuki Ii, Mitsuhisa Mutoh, Yu Katayose, Toshiki Rikiyama, Masaya Oikawa, Fuyuhiko Motoi, Shinichi Egawa, Takaaki Abe, Michiaki Unno.   

Abstract

Although some kinds of bile acids have been implicated in colorectal cancer development, the mechanism of cancer progression remains unexplored in hepatobiliary cancer. From our personal results using complementary DNA microarray, we found that chenodeoxycholic acid (CDCA) induced Snail expression in human carcinoma cell lines derived from hepatocellular carcinoma and cholangiocarcinoma. Snail expression plays an important role in the regulation of E-cadherin and in the acquisition of invasive potential in many types of human cancers including hepatocellular carcinoma. We found that CDCA and lithocholic acid (LCA) induced Snail expression in a concentration-dependent manner and down-regulated E-cadherin expression in hepatocellular carcinoma and cholangiocarcinoma cell lines. Moreover, Snail short interference RNA (siRNA) treatment reduced the down-regulation of E-cadherin by CDCA or LCA. Luciferase analysis demonstrated that the promoter region from -111 to -24 relative to the transcriptional start site was necessary for this induction and, at least in part, nuclear factor Y (NF-Y) and stimulating protein 1 (Sp1) might be an inducer of Snail expression in response to bile acids. In addition, using an in vitro wound healing assay and invasion assay, we observed that CDCA and LCA induced cell migration and invasion. These results suggest that bile acids repress E-cadherin through the induction of transcription factor Snail and increase cancer invasiveness in human hepatocellular carcinoma and cholangiocarcinoma. Inhibition of this bile acid-stimulated pathway may prove useful as an adjuvant in the therapy of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691339     DOI: 10.1111/j.1349-7006.2008.00898.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  14 in total

1.  The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue.

Authors:  Han-Hua Dong; Shuai Xiang; Xiao-Ping Chen; Hui-Fang Liang; Wei Zhang; Kai Jing; Wei Zhang; Wan-Guang Zhang; Lin Chen
Journal:  Stem Cells Dev       Date:  2009-11       Impact factor: 3.272

2.  VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Lihui Han; Wanhua Ren; Hui Liu; Chengyong Qin
Journal:  Future Oncol       Date:  2015-11-09       Impact factor: 3.404

3.  High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Wanhua Ren; Shifeng Xu; Zhen Yang; Aiju Fang; Chengyong Qin
Journal:  Med Oncol       Date:  2012-01-15       Impact factor: 3.064

4.  High expression of CCDC25 in cholangiocarcinoma tissue samples.

Authors:  Siriporn Proungvitaya; Wachiraya Klinthong; Tanakorn Proungvitaya; Temduang Limpaiboon; Patcharee Jearanaikoon; Sittiruk Roytrakul; Chaisiri Wongkham; Anongporn Nimboriboonporn; Sopit Wongkham
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

5.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.

Authors:  Katryn Allen; Hartmut Jaeschke; Bryan L Copple
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 6.  Cholangiocarcinoma: new insights into disease pathogenesis and biology.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Infect Dis Clin North Am       Date:  2010-12       Impact factor: 5.982

7.  Helicobacter hepaticus--induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response.

Authors:  Alexis García; Yu Zeng; Sureshkumar Muthupalani; Zhongming Ge; Amanda Potter; Melissa W Mobley; Chakib Boussahmain; Yan Feng; John S Wishnok; James G Fox
Journal:  Cancer Res       Date:  2011-02-18       Impact factor: 12.701

8.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

9.  WTAP regulates migration and invasion of cholangiocarcinoma cells.

Authors:  Hong-Jae Jo; Hye-Eun Shim; Myoung-Eun Han; Hyun-Jung Kim; Ki-Sun Kim; Sungmin Baek; Kyung-Un Choi; Gi-Yeong Hur; Sae-Ock Oh
Journal:  J Gastroenterol       Date:  2013-01-25       Impact factor: 7.527

10.  Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.

Authors:  Jan B Egan; Patricia A Thompson; Milen V Vitanov; Leonid Bartik; Elizabeth T Jacobs; Mark R Haussler; Eugene W Gerner; Peter W Jurutka
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.